SEC Form 4 · accession 0001179110-15-010612
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith Katkin
Director
Period of report
Jun 29, 2015
Accepted (ET)
Jul 1, 2015 · 5:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.26 | Jun 29, 2015 | A | 80,000 | A | — | Jun 29, 2025 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1The Option shall vest in equal monthly installments from June 29, 2015 and ending on the date of the Annual Meeting in 2016 at which the Optionholder is first scheduled to be considered for election to be a Non-Employee Director by the stockholders of the Company.